tianeptine - Page 1 | WholeFoods Magazine

CHPA Survey: 92% Say Supplements Have Had a Positive Impact on Their Health

With 2025 data highlighting widespread consumer use and value in supplements, CHPA outlines a comprehensive approach to protect consumers, build trust, and strengthen the supplement industry.

June 21, 2025

WholeFoods Magazine Staff

CHPA said its survey results show "clear support" for modernizing the regulations overseeing dietary supplements.

Durbin Introduces Dietary Supplement Listing Act of 2024

The latest efforts on mandatory product listing.

July 30, 2024

Maggie Jaqua, Content Director

The Dietary Supplement Listing Act of 2024 would require dietary supplement manufacturers to list their products with FDA.

Various color pills and capsules with wooden dispenser on white background

NPA: Durbin/Pallone Bill Would Grant FDA Authority to Prohibit the Marketing of Products

The association outlined key concerns with the legislation and issued a call to action for natural products industry members.

April 26, 2024

Maggie Jaqua, Content Director

Legislation (HR 8123) introduced by Representative Frank Pallone (D-NJ) and Senator Dick Durbin (D-IL) aims to amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.

Industry Groups Respond to Durbin Letter Calling for DSHEA Modernization

Sen. Durbin pointed to tianeptine as a reason for mandatory product listing.

March 20, 2024

WholeFoods Magazine Staff

The modernization of DSHEA and mandatory product listing for dietary supplements as been a hot topic in the natural products industry for years. Here's the latest.

Exclamation point in line art style. Vector illustration.

CRN Issues Warning on Tianeptine-Containing Fake Supplement Products

The association cautioned: "These products are often illegally marketed as dietary supplements and can pose significant health risks."

January 25, 2024

WholeFoods Magazine Staff

CRN and FDA have issued warnings to consumers: Do not purchase or use products containing tianeptine.

FDA Issues Warning on Products Making Opioid-Related Claims

November 22, 2018

WholeFoods Magazine Staff

Washington, D.C.— Following reports of serious adverse events associated with the use of tianeptine, the U.S. Food and Drug Administration (FDA) has issued warning letters to two companies for the illegal marketing of products labeled as dietary supplements that contain the chemical compound. Tianeptine is not approved for any...